首页> 外国专利> INHIBITORS OF THE INHIBITOR FACTOR OF THE MIGRATION OF MACROPHAGES AND METHODS FOR IDENTIFICATION.

INHIBITORS OF THE INHIBITOR FACTOR OF THE MIGRATION OF MACROPHAGES AND METHODS FOR IDENTIFICATION.

机译:巨噬细胞迁移抑制因子的抑制剂和鉴定方法。

摘要

A compound with structure: ** (See formula) ** or a stereoisomer, or a pharmaceutically acceptable salt thereof, where: X is oxygen; Y is selected from the group consisting of -NO2, -C (= O) R5, -C (= O) OR5 and -C (= O) NR5R6; Z is -CH2-; n is 1; R1 is selected from the group consisting of hydrogen, C1-10 alkyl, C1-10 aryl alkyl, phenyl, naphthyl, 5-7 membered monocyclic heterocycle and 7 to 14 membered polycyclic heterocycle, where R1 is substituted or not with at least a substituent selected from the group consisting of halogen, alkoxy, alkylamino, dialkylamino and keto; R2 and R3 are independently selected from the group consisting of halogen, hydrogen and C1-10 alkyl; R4 is selected from the group consisting of -CH2R7, -C (= O) NR5R6, -C (= O) OR7 and -C (= O) R7; each R5 and R6 is independently selected from the group consisting of hydrogen, C1-10 alkyl and C1-10 aryl alkyl; or R5 and R6 together with a nitrogen atom to which they are attached form a 5 to 7 membered monocyclic heterocycle or a 7 to 14 membered polycyclic heterocycle, where R5 and R6 are independently substituted or not with at least one substituent selected from the group formed by halogen, alkoxy, alkylamino, dialkylamino and keto; R7 is selected from the group consisting of C1-10 alkyl, C1-10 aryl alkyl, phenyl, naphthyl, 5-7 membered monocyclic heterocycle and 7 to 14 membered polycyclic heterocycle, where R7 is substituted or not with at least one substituent selected from the group consisting of halogen, alkoxy, alkylamino, dialkylamino and keto.
机译:具有以下结构的化合物:**(参见式)**或立体异构体或其药学上可接受的盐,其中:X为氧; Y选自-NO 2,-C(= O)R 5,-C(= O)OR 5和-C(= O)NR 5 R 6。 Z为-CH 2-; n为1; R1选自氢,C1-10烷基,C1-10芳烷基,苯基,萘基,5-7元单环杂环和7-14元多环杂环,其中R1被至少一个取代基取代或未被取代。选自卤素,烷氧基,烷基氨基,二烷基氨基和酮基; R2和R3独立地选自卤素,氢和C1-10烷基; R4选自-CH2R7,-C(= O)NR5R6,-C(= O)OR7和-C(= O)R7; R5和R6各自独立地选自氢,C1-10烷基和C1-10芳基烷基;或R 5和R 6与它们所连接的氮原子一起形成5至7元单环杂环或7至14元多环杂环,其中R 5和R 6独立地或不被至少一个选自形成的组的取代基取代通过卤素,烷氧基,烷基氨基,二烷基氨基和酮基; R7选自C1-10烷基,C1-10芳烷基,苯基,萘基,5-7元单环杂环和7-14元多环杂环,其中R7被至少一个选自以下的取代基取代或不被取代卤素,烷氧基,烷基氨基,二烷基氨基和酮组成的组。

著录项

  • 公开/公告号ES2342877T3

    专利类型

  • 公开/公告日2010-07-16

    原文格式PDF

  • 申请/专利权人 AVANIR PHARMACEUTICALS;

    申请/专利号ES20020731971T

  • 申请日2002-05-24

  • 分类号C07D215/42;C12Q1/02;A61K31/47;A61K31/4706;A61K31/4709;A61K31/496;A61K31/497;A61K45;A61P1/04;A61P3/10;A61P5/08;A61P5/46;A61P9;A61P11;A61P11/06;A61P13/12;A61P19/02;A61P25/28;A61P29;A61P35;A61P37/06;A61P43;C07D215/46;C07D215/54;C07D401/12;C07D405/12;C07D409/12;C07D409/14;C07D413/12;C07D417/12;

  • 国家 ES

  • 入库时间 2022-08-21 18:43:03

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号